To read the full 2022 i&E OKBIO Edition, click here.Read more
By Scott Meacham In this Thanksgiving week, I am reminded of all that we here in Oklahoma have to be grateful for—our friends, neighbors, and co-workers; the natural resources and beauty of our state, and, especially, the tenacity and creativity that is such a driver of entrepreneurship and new company and new job creation. IfRead more
By Jim Stafford Copyright ©2018, The Oklahoma Publishing Co. For the 300 million people worldwide who live with disabling hearing loss, few alternatives exist to restore their critical sense of hearing. Hearing aids. Cochlear implants. And little else. Both alternatives are too expensive for most of the world’s population to afford. “Hearing aids cost aboutRead more
By Scott Meacham Copyright © 2017, The Oklahoma Publishing Co. Does anyone in your life suffer from hearing loss? In the U.S., hearing loss impacts the daily lives of 48 million people from young to old — in classrooms, in conversation, in business and social settings, even at home as they watch a football gameRead more
A pair of investment funds managed by i2E, Inc., recently closed a $1.2 million investment in Oklahoma City’s Otologic Pharmaceutics, Inc., a company developing novel treatments for hearing disorders.